Global Multiple Myeloma Market to grow at a CAGR of 4.8% and reach $ Global Multiple Myeloma Market to grow at a CAGR o | Page 3




Lenalidomide (Revlimid)
Arsenic trioxide (Trisenox)
Plerixafor (Mozobil)
Based on geography the market is analysed under various regions namely, North America,
Latin America, Europe, Asia-Pacific and Middle-East & Africa. North America dominated the
market with highest revenue because of stability of key manufacturers in the region. Due to
increase in geriatric population in the countries like China and India, Asia-Pacific is expected
to witness highest growth rate in the forecast period.
 North America Multiple Myeloma Market
 Europe Multiple Myeloma Market
 Asia-Pacific Multiple Myeloma Market
 Latin America Multiple Myeloma Market
 Middle East and Africa Multiple Myeloma Market
Some of the key contributors in the industry include AB Science SA, AbbVie Inc., Ablynx NV,
Acceleron Pharma Inc., IGF Oncology LLC. , ImmunGene Inc., Millennium Pharmaceuticals
Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A.,
Terpenoid Therapeutics Inc. ,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and
Johnson and Johnson.
The Multiple Myeloma Market study offers the following deliverables:




Global, regional and country-level analysis and forecasts of the study market;
providing Insights on the geographical areas in which this industry is blooming
Segment-level analysis on basis of producttype, application, colour along with
market size forecasts and y-o-y estimations to detect key areas of industry growth in
detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the
market and their impact on shifting market dynamics
Study of macro and micro environmental factors that effect the global market
presented in an extensive strategic analyses section containing PESTLE and Porter’s
Five Forces Analyses